View this Special Report as a PDF
The Uphill Battle: Challenging Bio-Pharma in IPRs
Since the Hatch-Waxman Act has been in effect, there has been an increase in the number of challenges to patents covering chemical compounds. With the advent of inter partes reviews, the expectation was that there would be an uptick in compound claims being found obvious due to the expertise of the Patent Trial and Appeal Board. That has not been the case. Instead, as outlined here, the exact opposite has happened.
Guidance on Enforcing and Defending Intellectual Property Rights on Amazon
As Amazon continues to grow and change the retail landscape, it is increasingly important for attorneys to have the tools to assist clients in navigating infringement issues on Amazon.
Computer Generated Models: Intellectual Property and Advertising Risks
Virtual models and influencers may function as trademarks, as works of visual art, as likenesses of real people, or as combinations of all three, raising new issues of intellectual property ownership and protection and implicate right of publicity and/or privacy concerns. CGI models and advertisements featuring them could also be subject to regulatory scrutiny both at the federal and state levels.
Alexa, Will I Be Able to Patent My Artificial Intelligence Technology This Year?
Considering the advances in AI technology and intellectual property law, how do these recent developments shape the outlook of AI patentability?
Seeking International Patent Infringement Damages in a Post-’WesternGeco’ World
The full implications of the Supreme Court’s ‘WesternGeco’ decision are still unclear. Nevertheless, as expected, multinational defendants are advocating for a narrow reading of the case, whereas patentee plaintiffs are advocating for an expansive reading.
My House: What Rules? IP Implications of Augmented Reality Advertising
The intersection of real-world objects with digital images will test a number of legal doctrines.